Titlebook: Competition Law and Policy in the Japanese Pharmaceutical Sector; Akira Negishi,Masako Wakui,Naoko Mariyama Book 2022 The Editor(s) (if ap

glacial

Competition and Cooperation: Building a Sustainable Healthcare Delivery System in a Society with a D regulatory reforms in the healthcare delivery system, including the introduction of collaboration promotion policies. The urgent demand for medical care that arose in 2020 to cope with the COVID-19 pandemic further demonstrates the necessity of a sustainable healthcare delivery system. This require

nitroglycerin

Drug Regulation in Japanvelopment (R&D) and create new businesses are set out in the Health and Medical Care Strategy Promotion Act. The rules regulating medical research are established based on the Declaration of Helsinki. Additionally, the Clinical Research Act and other legal rules exist to ensure citizens’ trust in cl

intuition

Collaboration Between the Patent System and Pharmaceutical Regulations for Drug-Discovery Innovationtection) are crucial to dominating the competition in drug development. Monopolisation of pharmaceuticals is enforceable by Japanese patent and pharmaceutical regulations. Pharmaceutical regulations partly define the scope and duration of patent rights. On the other hand, they themselves are a means